Ok so from the last quarterly IHL-216A for Concussion and Traumatic Brain Injury is expected to be done, hopefully results soon
![https://hotcopper.com.au/data/attachments/4238/4238374-784461ba76f7a72271134f2203f4b267.jpg](https://hotcopper.com.au/data/attachments/4238/4238374-784461ba76f7a72271134f2203f4b267.jpg)
and on track
![https://hotcopper.com.au/data/attachments/4238/4238378-96609d68340073b91666b45bba72fa21.jpg](https://hotcopper.com.au/data/attachments/4238/4238378-96609d68340073b91666b45bba72fa21.jpg)
For IHL-675A multi-use drug candidate for Lung Inflammation, Rheumatoid Arthritis, and Inflammatory Bowel Disease, trial should have begun Q4 2021
![https://hotcopper.com.au/data/attachments/4238/4238383-4b7206cbf70269ec6abac43b05ee9f62.jpg](https://hotcopper.com.au/data/attachments/4238/4238383-4b7206cbf70269ec6abac43b05ee9f62.jpg)
Results must be due soon based on this:
![https://hotcopper.com.au/data/attachments/4238/4238385-d573ca81dbd9b725f29ffb7ee7c4fc21.jpg](https://hotcopper.com.au/data/attachments/4238/4238385-d573ca81dbd9b725f29ffb7ee7c4fc21.jpg)
For IHL-42X for Obstructive Sleep Apnoea the Company has been granted a pre-IND meeting with FDA on May 11. Planning commences for pivotal clinical trials to commence after opening an IND with FDA. So should get feedback this quarter.
![https://hotcopper.com.au/data/attachments/4238/4238389-ee3129e2d53d0a17ebb8b4bc8f602bfe.jpg](https://hotcopper.com.au/data/attachments/4238/4238389-ee3129e2d53d0a17ebb8b4bc8f602bfe.jpg)
For Psilocybin-assisted Psychotherapy for General Anxiety Disorder (Psi-GAD). As per the last quarterly therapist training for the phase 2a trial assessing psilocybin-assisted therapy for Generalised Anxiety Disorder is completed; patient recruitment to commence imminently. So probably not much on this until Q3?
![https://hotcopper.com.au/data/attachments/4238/4238392-b16821fab01f9f0a9a7e2159f6490be4.jpg](https://hotcopper.com.au/data/attachments/4238/4238392-b16821fab01f9f0a9a7e2159f6490be4.jpg)
Also - aren't we waiting on a second psychedelics trial to be announced? See
hereAnd they need to explain to us what this acquisition is all about
Plenty of fish to fry in Q2 2022